NCT02274389View on ClinicalTrials.gov

A Prospective Patient Registry of Patients Exposed to Bedaquiline

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

December 24, 2013

Primary Completion Date

November 20, 2018

Study Completion Date

November 20, 2018

Conditions
Pulmonary Multi-drug Resistant Tuberculosis
Interventions
DRUG

No Intervention

This is an observational study and participants did not receive any intervention in this study. Participants initiating bedaquiline (BDQ) treatment as decided by healthcare provider, will be prospectively observed.

Trial Locations (1)

Unknown

Raleigh

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT02274389 - A Prospective Patient Registry of Patients Exposed to Bedaquiline | Biotech Hunter | Biotech Hunter